Investing.com - Financial Markets Worldwide

ProKidney Corp (PROK)

NASDAQ
Currency in USD
1.870
+0.140(+8.09%)
Closed·
After Hours
1.890+0.020(+1.07%)
·

PROK Comments

pro badge
Lets do it
pro badge
Today will jump 5 at least
pro badge
Going 9 sooooon
In my opinion, 9 is not achievable, 6 is not even achievable at the moment, only when phase 3 is released and the result is positive, it will be even 20
pro badge
Can fly to 9 ??
pro badge
Up up
Mybe over than 9$ fir more than 100%profit
🚀 ProKidney (PROK) Just Surged Nearly 20%! Can It Climb From $2 to Over $14? ProKidney (PROK) just surged nearly 20% over the last two trading sessions, and they’re making big moves in the chronic kidney disease (CKD) space with two Phase 3 trials back in action. What's even more intriguing is that they didn’t just raise $140M in their latest offering—they already had $329M in the bank. Now, with $431.5M in cash and a market cap of only $500M, their cash reserves nearly match their entire valuation! A key reason for the recent price drop was the halt in their manufacturing operations, which had been paused for several months. This info, revealed in their Q2 report on August 9, also highlighted that manufacturing has now resumed. 📈 They've restarted their PROACT 1 and 2 trials, aiming to meet the unmet needs of late-stage CKD patients. ProKidney is also strategically targeting patients with advanced CKD, a niche where current therapies are insufficient, potentially positioning rilparencel as a "blockbuster" therapy. Despite competition from GLP-1 agonists, ProKidney’s focus on the most severe cases could allow it to carve out a significant market share. And get this—BofA Securities just revised their forecasts upwards for ProKidney's cell therapy drug, REACT, now expecting peak sales to hit $1.8 billion. 😲 To top it off, Pablo Legorreta, the billionaire founder of Royalty Pharma, invested €57M of his own cash into this. That’s a huge vote of confidence. With these developments, some speculate that PROK could climb back to its all-time high of $14—or even higher—by the end of the year. This stock seems to have serious potential! What do you all think? Let’s hear your thoughts!
4$ whithin the end of the month! This is a millionaire making stock!
I bought it with my last money at 1.40, I found out only now, this prok can only go to the expense )))
you are rich now
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.